**INTRODUCTION:** Adverse perioperative events (APE) complicate 5--30% of cleft palate repairs,^1^ causing significant morbidity, distress, and prolonged hospitalizations. While syndromic diagnosis and young age have been implicated as APE risk factors in general anesthesia, individual risk remains difficult to predict. This study prospectively validates a previously-developed risk assessment tool which estimates individual risk for APEs after cleft palatoplasty.

**METHODS:** A prospective cohort of patients under 2 years having primary Furlow palatoplasty were reviewed for medical history and perioperative data. APEs were defined as laryngobronchospasm, accidental extubation, reintubation, obstruction, hypoxia, and unplanned ICU admission. Multivariate regression modeling, risk factor stratification, and model performance were assessed.

**RESULTS:** 190 patients averaging 11.7 months were included. Veau Cleft distribution included: Submucosal-13.9%, I-14.9%, II-31.4%, III-32.0%, IV-7.7%. Pierre Robin (PRS) (N=29) was the most prevalent syndrome/anomaly. 60% of patients received paralytic reversal and total narcotic dose averaged 0.17 mg/kg. APEs occurred in 31 patients (16.3%): hypoxia (11.6%), airway obstruction (6.3%), unplanned ICU (6.3%), laryngobronchospasm (2.1%) reintubation (1.1%).

Adjusted regression analysis for APEs identified risk factors including higher perioperative narcotic administration (\> 0.32 mg/kg OR=11.6, p=0.004), abnormal airway anatomy (OR=4.52, p=0.045), 2+ intubation attempts (OR=4.43, p=0.006), history of reactive airway disease (OR=4.11, p=0.029), and syndrome other than PRS (OR=2.74, p=0.05). Protective factors included administration of reversal agent (OR=0.37, p=0.05) and use of gelfoam packing (OR=0.25, p=0.04). Patients were risk-stratified according to individual profiles as low (APE: 2.1%), average (APE: 5.7%), high (APE: 37.8%), or extreme risk (APE: 88.9%). Validation against our prior predictive tool found this prospective risk model was significantly more accurate with C-statistic=0.87 vs. C-statistic=0.74 (p=0.002).^2^

**CONCLUSION:** APEs occurred in 16.3% of palatoplasties. Higher opioid doses, multiple intubation attempts, and syndromes not including PRS imparted significant perioperative risk while use of paralytic reversal agents was consistently protective. Validated prospective risk-assessment tools such as this provide discrete strategies^3^ for reducing risk and may better inform patient selection and perioperative management in an evidence-based manner.
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